Let's check out the charts of this company that has a treatment of atherosclerotic cardiovascular disease through "differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque."
In the daily bar chart of SWAV, below, we can see that the shares have rallied three-fold in just the past 12 months. Prices have made some temporary or short-lived dips below the rising 50-day moving average line but have remained firmly above the positively sloped 200-day line.
The On-Balance-Volume (OBV) line has moved in a positive direction as traders have been more aggressive buyers than sellers. The trend-following Moving Average Convergence Divergence (MACD) oscillator has spent most of the past year above the zero line in buy territory but is currently in a decline.